Comparison of cholesterol-lowering efficacy and anti-atherogenic properties of hydrogenated versus non-hydrogenated (Phytrol™) tall oil-derived phytosterols in Apo E-deficient mice

Cardiovascular Drugs and Therapy

Volumn 17, Issue 5-6, 2003, Pages 443-449

  Pritchard, P Haydn ^a   Li, Min ^b   Zamfir, Catalina ^a   Lukic, Tatjana ^b   Novak, Egon ^b   Moghadasian, Mohammed H ^c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Forbes Medi Tech Inc   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Apo E KO mice; Atherosclerosis; Plant sterols and stanols; Plasma cholesterol

Indexed keywords

APOLIPOPROTEIN E; CAMPESTEROL; FCP 3P1; FCP 3P2; HYPOCHOLESTEROLEMIC AGENT; PHYTOSTEROL; PHYTROL; SITOSTANOL; SITOSTEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HYDROGENATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VASCULAR LESION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BODY WEIGHT; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGENATION; MALE; MICE; MICE, INBRED C57BL; PHYTOSTEROLS; PLANT OILS; STEROLS;

EID: 1542719737     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CARD.0000015859.37581.f1     Document Type: Article

References (32)

1. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-2828.
2. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit: A new look at old data. Circulation 1995;91:2274-2282.
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2491.
4. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-372.
5. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Serum cholesterol lowering by sitostanol ester margarine in a mildly hypercholesterolemic random population. N Engl J Med 1995;333:1308-1312.
6. Gylling H, Miettinen TA. Cholesterol reduction by different plant stanol mixtures and with variable fat intake. Metabolism 1999;48:575-580.
7. Hallikainen MA, Sarkkinen ES, Uusitupa MI. Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J Nutr 2000;130:767-776.
8. Tammi A, Ronnemaa T, Gylling H, et al. Plant stanol ester margarine lowers serum total and low-density lipoprotein cholesterol concentrations of healthy children: The STRIP project. Special Turku Coronary Risk Factors Intervention Project. J Pediatr 2000;136:503-510.
9. Heinemann T, Kullak-Ublick GA, Pietruck B, von Bergmann K. Mechanisms of action of plant sterols on inhibition of cholesterol absorption. Comparison of sitosterol and sitostanol. Eur J Clin Pharmacol 1991;40(Suppl 1):S59-S63.
10. Ikeda I, Sugano M. Inhibition of cholesterol absorption by plant sterols for mass intervention. Curr Opin Lipidol 1998;9:527-531.
11. Law M. Plant sterol and stanol margarines and health. BMJ 2000;320:861-864.
12. Philips C, Belsey J, Shindler J. Flora pro.activ: A clinical and financial impact analysis. J Med Econ 2000;3:61-76.
13. Moghadasian MH, Frohlich JJ. Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: Clinical and experimental evidence. Am J Med 1999;107:588-594.
14. Moghadasian MH, McManus BM, Pritchard PH, Frohlich JJ. "Tall oil"-derived phytosterols reduce atherosclerosis in Apo E-deficient mice. Arterioscler Thromb Vasc Biol 1997;17:119-126.
15. Moghadasian MH, McManus BM, Godin DV, Rodrigues B, Frohlich JJ. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: Possible mechanisms of action. Circulation 1999;99:1733-1739.
16. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-353.
17. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;468-471.
18. Jones PJ, Ntanios FY, Raeini-Sarjaz M, Vanstone CA. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am J Clin Nutr 1999;69:1144-1150.
19. Sugano M, Morioka H, Ikeda IA. Comparison of hypocholesterolemic activity of beta-sitosterol and beta-sitostanol in rats. J Nutr 1977;107:2011-2019.
20. Ikeda I, Morioka H, Sugano M. The effect of dietary alpha-sitosterol and alpha-sitostanol on the metabolism of cholesterol in rats. Agric Biol Chem 1979;43:1927-1933.
21. Nitanios FY, Jones PJH. Dietary sitostanol reciprocally influences cholesterol absorption and biosynthesis in hamsters and rabbits. Atherosclerosis 1999;143:341-351.
22. Weststrate JA, Meijer GW. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1998;52:334-343.
23. Moghadasian MH, Nguyen LB, Shefer S, McManus BM, Frohlich JJ. Histologic, hematologic, and biochemical characteristics of apo E-deficient mice: Effects of dietary cholesterol and phytosterols. Lab Invest 1999;79:355-364.
24. Zhang SH, Reddick RL, Burkey B, Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 1994;94:937-945.
25. Moghadasian MH, McManus BM, Nguyen LB, et al. Pathophysiology of apolipoprotein E deficiency in mice: Relevance to apo E-related disorders in humans. FASEB J 2001;15:2623-2630.
26. Hendriks HF, Weststrate JA, van Vliet T, Meijer GW. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1999;53:319-327.
27. Hallikainen MA, Sarkkinen ES, Uusitupa MIJ. Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J Nutr 2000;130:767-776.
28. Moghadasian MH, Frohlich JJ, Scudamore CH. Specificity of the commonly used enzymatic assay for plasma cholesterol determination. J Clin Pathol 2002;55:859-861.
29. Moghadasian MH, Nguyen LB, Shefer S, Salen G, Batta AK, Frohlich JJ. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment. Metabolism 2001;50:708-714.
30. Weisweiler P, Heinemann V, Schwandt P. Serum lipoproteins and lecithin: Cholesterol acyltransferase (LCAT) activity in hypercholesterolemic subjects given beta-sitosterol. Int Clin Pharmacol 1984;22:204-206.
31. Salen G, Ahrens EH Jr, Grundy SM. Metabolism of beta-sitosterol in man. Clin Invest 1970;49:952-967.
32. Denke MA. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr 1995;61:392-396.